Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001193125-17-195968
Filing Date
2017-06-06
Accepted
2017-06-06 16:13:33
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-4/A d177072ds4a.htm S-4/A 4279151
2 EX-23.1 d177072dex231.htm EX-23.1 1944
3 EX-23.2 d177072dex232.htm EX-23.2 1975
4 GRAPHIC g177072g01f90.jpg GRAPHIC 41154
5 GRAPHIC g177072g40g89.jpg GRAPHIC 24404
6 GRAPHIC g177072g59z18.jpg GRAPHIC 34746
7 GRAPHIC g177072g96p92.jpg GRAPHIC 30329
  Complete submission text file 0001193125-17-195968.txt   4464361
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-216961 | Film No.: 17894300
SIC: 2835 In Vitro & In Vivo Diagnostic Substances